Skip to main navigation Skip to search Skip to main content

A Phase 2b Randomised, Double-Blind, Parallel-Group Study Of Alginate Oligosaccharide (Oligog) Dry Powder Inhalation In Addition To Standard Of Care Compared To Placebo In Addition To Standard Of Care In Patients With Cystic Fibrosis (CF)

  • Daley, Chris (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/MML/51202 (V4)
NMA SSA Reference Number: SSA/51202/MonH-2019-170114(v3)
Monash Health Ref: RES-19-0000-254X
StatusFinished
Effective start/end date26/04/19 → 25/04/24

Keywords

  • clinical trial
  • phase 2 study
  • cystic fibrosis
  • treatment efficacy

Clinical Trial Phase

  • Phase II